Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Sana Biotechnology, Inc. (SANA : NSDQ)
 
 • Company Description   
Sana Biotechnology Inc. is focused on creating and delivering engineered cells as medicines for patients. The company involved in repairing and controlling genes, replacing missing or damaged cells as well as making its therapies. Sana Biotechnology Inc. is based in SEATTLE.

Number of Employees: 383

 
 • Price / Volume Information   
Yesterday's Closing Price: $4.48 Daily Weekly Monthly
20 Day Moving Average: 1,718,183 shares
Shares Outstanding: 189.67 (millions)
Market Capitalization: $849.71 (millions)
Beta: 1.40
52 Week High: $26.60
52 Week Low: $4.17
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -40.43% -34.77%
12 Week -30.86% -22.30%
Year To Date -71.06% -64.64%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
188 EAST BLAINE STREET SUIT 400
-
SEATTLE,WA 98102
USA
ph: 206-701-7914
fax: -
investor.relations@sana.com http://www.sana.com
 
 • General Corporate Information   
Officers
Steven D. Harr - Chief Executive Officer; President and Director
Hans E. Bishop - Chairman
Nathan Hardy - Chief Financial Officer
Joshua H. Bilenker - Director
Douglas Cole - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 799566104
SIC: 2836
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/03/22
Share - Related Items
Shares Outstanding: 189.67
Most Recent Split Date: (:1)
Beta: 1.40
Market Capitalization: $849.71 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.46 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.40 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 32.16% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/03/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.21
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -4.44%
vs. Previous Quarter: 27.69%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -41.87
12/31/21 - -35.63
09/30/21 - -40.60
ROA
03/31/22 - -28.39
12/31/21 - -24.20
09/30/21 - -19.70
Current Ratio
03/31/22 - 5.60
12/31/21 - 5.62
09/30/21 - 6.66
Quick Ratio
03/31/22 - 5.60
12/31/21 - 5.62
09/30/21 - 6.66
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - 3.70
12/31/21 - 3.86
09/30/21 - 4.42
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©